Michelle LeRoux Williams - 01 Jan 2026 Form 4 Insider Report for ELUTIA INC. (ELUT)

Reporting relationship: CHIEF SCIENTIFIC OFFICER
Issuer ticker: ELUT
Reported as of: 01 Jan 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 05 Jan 2026, 17:00:18 UTC
Prior SEC filing: 12 Dec 2025
Next SEC filing: 12 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Jeffrey Hamet, Attorney-in-Fact for Michelle LeRoux Williams

Key filing fact

Michelle LeRoux Williams filed Form 4 for ELUTIA INC. (ELUT) on 05 Jan 2026.

Key facts

This page summarizes Michelle LeRoux Williams's Form 4 filing for ELUTIA INC. (ELUT).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 05 Jan 2026, 17:00.

Change

Previous filing in this sequence was filed on 12 Dec 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001398249 Primary reporting owner

Williams Michelle LeRoux

Relationship: CHIEF SCIENTIFIC OFFICER
Address: C/O ELUTIA INC., 20 FIRSTFIELD ROAD, GAITHERSBURG
Signature: /s/ Jeffrey Hamet, Attorney-in-Fact for Michelle LeRoux Williams
Signature date: 05 Jan 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ELUT transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +368,000
Change %
Price: $0.000000
Shares after: 368,000
Date: 01 Jan 2026
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 368,000
Exercise price: $0.6900
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The option vests monthly over four years beginning one month after grant date such that the option shall be fully vested and exercisable on January 1, 2030.